MedPath

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

Not Applicable
Completed
Conditions
Morbid Obesity
Weight Loss
Interventions
Procedure: gastric bypass
Registration Number
NCT01514799
Lead Sponsor
Aleris Obesity
Brief Summary

Super Obesity, i.e. a BMI above 50, is difficult to treat. Normal gastric bypass surgery is not always enough for proper weight control. Bypassing a longer segment of the gut may be more beneficial. Which part to bypass is not clear.

The investigators want to compare the effects between preventing a 60 cm proximal (oral) portion of the jejunum from food contact with the effects when preventing a 200 cm part of the jejunum from contact with bile and pancreatic juice.

Endpoints are quality of life, gastrointestinal function, and weight development.

Detailed Description

Two variations of gastric bypass are compared:

Method 1 (test method):A 200 cm BP-limb (distance Treitz to EA) + 150 cm common channel (EA to ileocecal valve) + Roux-Y-limb variable Method 2 (standard method): A 60 cm BP limb + 150 cm Roux-Y-limb + common channel variable.

Patients are evaluated according to the principles of the Scandinavian Obesity surgery registry (SOReg) with the addition of two additional questionnaires.

FU time is set at 5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria
  • BMI 50-65
  • Age 18-55
  • Conservative attempts at weight reduction failed
Exclusion Criteria
  • Inability to speak and understand the Swedish language
  • Residence outside the county of Skåne
  • Psychotic disease
  • Inflammatory bowel disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Long BP limbgastric bypass200 cm BP limb
standard length bp limb, long alimentary limbgastric bypassour normal way of doing a gastric bypass 60 cm BP limb
Primary Outcome Measures
NameTimeMethod
body weight reduction5 years

absolute BW reduction, percentage of patients reaching BMI below 30,

Secondary Outcome Measures
NameTimeMethod
gastrointestinal function5 years

SF-36, Op-9, GSRS and TFEQ are used in patient assessed variables

Trial Locations

Locations (1)

Aleris Obesity Skåne

🇸🇪

Lund, Sweden

© Copyright 2025. All Rights Reserved by MedPath